(Q41635056)

English

Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation

scientific article published on 22 November 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

author name string

S Pecetta

1

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

P Lo Surdo

2

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

M Tontini

3

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

D Proietti

4

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

C Zambonelli

5

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

M J Bottomley

6

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

M Biagini

7

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

F Berti

8

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

P Costantino

9

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

M R Romano

10

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Study Group

11

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

language of work or name

0 references

publication date

22 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

314-320

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Global epidemiology of invasive meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Neonatal and infantile immune responses to encapsulated bacteria and conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

The design of semi-synthetic and synthetic glycoconjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Menveo®): a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Quadrivalent meningococcal conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

MenACWY-TT vaccine for active immunization against invasive meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Protein carriers of conjugate vaccines: characteristics, development, and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Antibody avidity determination by ELISA using thiocyanate elution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM197 conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

The use of circular dichroism in the investigation of protein structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Glycoconjugate vaccines and immune interference: A review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.11.026

7 January 2021

Identifiers

10.1016/J.VACCINE.2014.11.026

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41635056&oldid=1925359747"